Lessons learnt from gefitinib and erlotinib: Key insights into small-molecule EGFR-targeted kinase inhibitors in non-small cell lung cancer

Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Eckart LaackCarsten Bokemeyer

Abstract

Improving treatment options and patient outcomes for those with non-small cell lung cancer (NSCLC) represents a significant worldwide challenge. Although traditional treatment strategies are widely accepted and initially successful, many tumors still fail to respond to available drugs. Therapeutic options for patients with NSCLC are therefore moving towards more individual and personalized treatment strategies. The first-generation tyrosine kinase inhibitors (TKIs), designed to target specific molecular pathways within the tumor, have paved the way towards tailored therapy. Promising experience with these agents has opened the door to a sudden surge of new drug advances. The development of these second-generation treatments offer the potential to further maximize patient benefit and provide greater therapeutic options for patients with advanced NSCLC. As the number of second-generation TKIs continues to grow, the efficacy and safety of new members of this class continue to be established in ongoing clinical trials.

References

Jul 1, 1995·Critical Reviews in Oncology/hematology·D S SalomonN Normanno
Jan 11, 2002·The New England Journal of Medicine·Joan H SchillerUNKNOWN Eastern Cooperative Oncology Group
Dec 6, 2003·The Oncologist·Maarten L Janmaat, Giuseppe Giaccone
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Giuseppe GiacconeDavid H Johnson
Mar 3, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstDavid H Johnson
Aug 27, 2004·Proceedings of the National Academy of Sciences of the United States of America·William PaoHarold Varmus
Feb 25, 2005·The New England Journal of Medicine·Susumu KobayashiBalázs Halmos
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Dae Ho LeeJin Soo Lee
Apr 29, 2005·Current Drug Targets·N NormannoD S Salomon
May 18, 2005·Proceedings of the National Academy of Sciences of the United States of America·Eunice L KwakDaniel A Haber
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Jul 27, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Roy S HerbstUNKNOWN TRIBUTE Investigator Group
Sep 29, 2005·PLoS Medicine·Heidi GreulichMatthew Meyerson
Nov 5, 2005·Nature Clinical Practice. Oncology·Giuseppe Giaccone, Jose Antonio Rodriguez
Dec 21, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Naruo YoshimuraMasahiro Fukuoka
Dec 31, 2005·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Seiji NihoYutaka Nishiwaki
Jan 19, 2006·The Annals of Pharmacotherapy·Michael H Nelson, Christian R Dolder
Jun 6, 2006·The Lancet Oncology·Fiona BlackhallNick Thatcher
Jul 11, 2006·Nature Reviews. Molecular Cell Biology·Ami Citri, Yosef Yarden
Sep 26, 2006·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Wei-Chun LinChun-Ming Tsai
Sep 27, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Maurizio Scaltriti, José Baselga
Feb 10, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistDaniel A Haber
Apr 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ulrich GatzemeierJoachim Von Pawel
May 15, 2007·Cancer Biology & Therapy·Yuki YuzaMatthew Meyerson
May 17, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Erminia MassarelliIgnacio I Wistuba
Aug 25, 2007·Annual Review of Medicine·Lecia V Sequist, Thomas J Lynch
Nov 21, 2007·Expert Review of Molecular Diagnostics·Tae-You KimYung-Jue Bang
Dec 21, 2007·Proceedings of the National Academy of Sciences of the United States of America·James BeanWilliam Pao
Jan 30, 2008·Proceedings of the National Academy of Sciences of the United States of America·Cai-Hong YunMichael J Eck
Feb 9, 2008·Cellular and Molecular Life Sciences : CMLS·M J Wieduwilt, M M Moasser
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Lecia V SequistThomas J Lynch
May 29, 2008·Seminars in Respiratory and Critical Care Medicine·Scott Gettinger
Jun 3, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kwok-Kin Wong
Jun 24, 2008·The Journal of Clinical Investigation·Marta GuixJeffrey A Engelman
Jul 4, 2008·The New England Journal of Medicine·Shyamala MaheswaranDaniel A Haber
Jan 6, 2009·Proceedings of the National Academy of Sciences of the United States of America·Samanthi A PereraKwok-Kin Wong
Feb 12, 2009·Current Opinion in Cell Biology·Nancy E Hynes, Gwen MacDonald
Mar 26, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Kwok-K WongHoward A Burris
Apr 1, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Winson Y CheungCraig C Earle

❮ Previous
Next ❯

Citations

May 11, 2011·International Journal of Environmental Research and Public Health·Agustin Lage, Tania Crombet
Mar 16, 2012·Future Medicinal Chemistry·Margaret S Lee
Mar 12, 2011·Bioorganic & Medicinal Chemistry Letters·Datta E PondeRamachandran Murali
Jul 25, 2012·Critical Reviews in Oncology/hematology·Beata Cunderlíková
Jun 8, 2018·Breathe·Clementine Bostantzoglou, Nir Peled
Jun 13, 2018·Clinical and Translational Medicine·Lillian TruongYong-Xiao Wang
May 21, 2016·Clinical Journal of Oncology Nursing·Kerrin SorrieAlethea Hill
Sep 21, 2019·Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·Z-X LiM-S Dong
Sep 1, 2020·Expert Opinion on Pharmacotherapy·Connor O'LearyPatrick Morris
Jul 15, 2016·International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group·Luby Sidoff, Damian E Dupuy
Sep 22, 2020·Expert Opinion on Drug Delivery·Archana UpadhyaAmbikanandan Misra
Jun 20, 2017·Thoracic Cancer·Won Na SuhJung Hyun Chang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Signaling by Tyrosine Kinases

Receptor tyrosine kinases (RTKs) are the high-affinity cell surface receptors for many polypeptide growth factors, cytokines, and hormones. RTKs have been shown not only to be key regulators of normal cellular processes but also to have a critical role in the development and progression of many types of cancer. Discover the latest research on cell signaling and RTK here.

Related Papers

Current Hematologic Malignancy Reports
Meinolf SuttorpFrederic Millot
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
Rikke SøgaardUlrik Lassen
Lung Cancer : Journal of the International Association for the Study of Lung Cancer
Martin Reck, Lucio Crinò
© 2021 Meta ULC. All rights reserved